Clinical Trials Logo

Syndrome clinical trials

View clinical trials related to Syndrome.

Filter by:

NCT ID: NCT04161027 Completed - Clinical trials for Restless Legs Syndrome

RCT for Pregabalin in Restless Legs Syndrome in South Korea

Start date: February 24, 2020
Phase: Phase 3
Study type: Interventional

This randomized, double-blind, placebo-controlled, multicenter clinical trial is designed to to assess the treatment efficacy and tolerability of pregabalin in patients with idiopathic restless legs syndrome in South Korea.

NCT ID: NCT04160052 Recruiting - Clinical trials for Myelodysplastic Syndrome

Venetoclax and Azacitidine for the Treatment of High-Risk Recurrent or Refractory Myelodysplastic Syndrome

Start date: October 1, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

This phase I/II trial studies the side effects and best dose of venetoclax when given together with azacitidine in treating patients with high-risk myelodysplastic syndrome that has come back (recurrent) or does not respond to treatment (refractory). Drugs used in chemotherapy, such as venetoclax and azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.

NCT ID: NCT04158427 Completed - Clinical trials for Microbial Colonization

Intestinal Microbiota and Chronic Fatigue Syndrome

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

Gut microbiota of 1) patients with chronic fatigue syndrome and 2) their healthy family members are analyzed. Up to 40 patients with chronic fatigue syndrome are randomized to receive either 1) a faecal transplant from a healthty donor or 2) their own feces via colonoscopy. Patient's health related quality and ability to work are assessed (baseline, 1 and 6 months after the procedure)

NCT ID: NCT04158219 Completed - Depression Clinical Trials

Healthy Heart Habits

H^3
Start date: November 15, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

Approximately 350,000 Acute Coronary Syndrome (ACS) patients experience significant depression symptoms each year in the US. Post-ACS depressed mood interferes with patients making necessary changes to behavioral risk factors (e.g., smoking cessation) and predicts poor medical outcomes. The proposed study will develop an integrated depression and behavioral risk factor reduction intervention for secondary prevention post-ACS through an open trial of 20 patients.

NCT ID: NCT04157946 Completed - Clinical trials for Respiratory Distress Syndrome, Adult

The Role of Morphological Phenotype in ARDS

MPARDS
Start date: August 7, 2017
Phase:
Study type: Observational

Although most of the information focuses on understanding how the ventilator produces lung damage, the pulmonary factors that predispose to ventilator-induced lung injury (VILI) have been less studied. Acute respiratory distress syndrome (ARDS) can adopt different morphological phenotypes, with its own clinical and mechanical characteristics. This morphological phenotypes may favor the development of VILI for same ventilatory strategy

NCT ID: NCT04156607 Completed - Down Syndrome Clinical Trials

The Effects of Kinesiotaping on Balance in Children With Down Syndrome.

Start date: February 25, 2018
Phase: N/A
Study type: Interventional

This study aimed to explore the effects of Kinesio tape applied to plantar soles on balance in children with Down Syndrome (DS). Two groups including children with DS and a group with their typically developing peers evaluated. Half of the children with DS took Kinesio tape application to the plantar soles and the other half took sham taping application. All children evaluated with dynamic and static balance measurements and DS children evaluated immediately after taping and 45 minutes after taping again with the same measurements.

NCT ID: NCT04156438 Completed - Clinical trials for Acute Respiratory Distress Syndrome

Airway Pressure Release Ventilation for Moderate-to-severe Acute Respiratory Distress Syndrome

EARL
Start date: June 29, 2020
Phase: N/A
Study type: Interventional

This study will examine the feasibility of a large clinical trial investigating the effectiveness of airway pressure release ventilation and low tidal volume ventilation for patients with moderate-to-severe acute respiratory distress syndrome.

NCT ID: NCT04154007 Completed - Acute Kidney Injury Clinical Trials

Acute Kidney Injury in Patients With Acute Respiratory Distress Syndrome

Start date: September 1, 2017
Phase:
Study type: Observational

Several studies suggested that ARDS may have important adverse effects on renal function, but few studies have specifically addressed the risk factors of AKI and its impact on the outcome in theses patients.

NCT ID: NCT04153201 Completed - Clinical trials for Antiphospholipid Syndrome

Hydroxychloroquine for Thrombosis Prevention and Antiphospholipid Antibody Reduction in Primary Antiphospholipid Syndrome

Start date: January 15, 2013
Phase: N/A
Study type: Interventional

This is an interventional drug study designed as a pilot for a randomized clinical trial, aimed at assessing the effect of hydroxychloroquine on the incidence rate of thrombosis in patients with primary antiphospholipid syndrome as the main outcome, as well as the safety of hydroxychloroquine administration in this population. In addition, the effect of hydroxychloroquine on antiphospholipid antibody titers will be assessed.

NCT ID: NCT04152395 Not yet recruiting - Metabolic Syndrome Clinical Trials

Metabolic Syndrome in Patients Undergoing Endovascular Aortic Repair (EVAR)

Start date: June 1, 2020
Phase:
Study type: Observational

This prospective study aims to identify the prevalence of metabolic syndrome in patients undergoing EVAR and the implications of metabolic syndrome on the postoperative outcome, the major complications, the thromboembolic events and the perioperative mortality and morbidity of the patients undergoing vascular surgery.